Risklick Company
Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials(CTs) and assess risks in early steps of the protocol design. CTs are used to determine the efficacy and safety of an experimental treatment; however, up to 90% of them fail in the early stage of protocol design and the nature and complexity of CTs make risk assessment difficult and time-consuming.
Employee Number:
11-50
Headquarters:
Bern, Bern, Switzerland, Europe
Founded Date:
2019-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 78 781 41 35
Investors:
Debiopharm Innovation Fund
Ipo Status:
private
City:
Bern
Region:
Bern
Country:
Switzerland
Founders:
Cedric Odje